In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n
Names of the companies and groups concerned:<\/strong><\/p>\n Nature<\/strong> of the operation:<\/strong><\/p>\n Economic sectors<\/strong> concerned:<\/strong><\/p>\n Deadline for interested third parties to submit their observations:<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council received notification of an economic concentration operation concerning the acquisition by the company \u201cLaprophan SA\u201d of the exclusive control of the company \u201cCorporate Investment Holding SA\u201d and its subsidiaries.<\/p>\n \u201cLaprophan SA\u201d is a Moroccan joint-stock company, headquartered at Km 7, Route de l\u2019unit\u00e9, A\u00efn Seba\u00e2, Route de Rabat, Casablanca, registered with the Casablanca Trade Register under number 16499. It is active in the production, import, and distribution of pharmaceutical specialties and dietary supplements in Morocco, with recent expansion internationally through the acquisition of a majority stake in the companies \u201cPian Holding BV\u201d, \u201cRivopharm Limited\u201d, and \u201cDouble E Pharma Limited\u201d.<\/p>\n \u201cCorporate Investment Holding SA\u201d is a Moroccan joint-stock company, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, Casablanca, registered with the Casablanca Trade Register under number 189919. It holds 98.4% of the share capital and voting rights of the company \u201cPolymedic SA\u201d, which itself holds 100% of the capital of the company \u201cSterilab SARL\u201d and associated voting rights. It also holds the entire share capital and voting rights of the companies \u201cPharmena SARLAU\u201d, \u201cPromaceutique SARLAU\u201d, and \u201cFonci\u00e8re Amyot SARLAU\u201d.<\/p>\n \u201cPolymedic SA\u201d is a Moroccan joint-stock company, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, Casablanca, registered with the Casablanca Trade Register under number 29277. It is a pharmaceutical laboratory active in the manufacture and marketing of generic drugs and licensed specialties, as well as in contract manufacturing for third parties. It also recently started marketing dietary supplements.<\/p>\n \u201cPharmena SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at Lot Dada, No. 77, Sal\u00e9, registered with the Sal\u00e9 Trade Register under number 18721. It is intended to be active in the distribution of dietary supplements and currently has no activity.<\/p>\n \u201cPromaceutique SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 632273. It is active in consulting as well as information and promotion services for health or cosmetic products on behalf of the CIH group.<\/p>\n \u201cFonci\u00e8re Amyot SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 632271. It is active in the acquisition, development, enhancement, and rehabilitation of real estate assets and holds the real estate assets of the entities affiliated with the company \u201cCorporate Investment Holding SA\u201d.<\/p>\n \u201cSterilab SARL\u201d is a limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 153299. It is intended to be active in the marketing of parapharmaceutical products, hygiene products, and medical equipment and currently has no activity.<\/p>\n <\/p>\n Done in Rabat, on October 22, 2026<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups concerned: The acquirer: the company \u201cLaprophan SA\u201d; The target: the company \u201cCorporate Investment Holding SA\u201d and its subsidiaries. Nature of the operation: Exclusive control acquisition. Economic sectors concerned: Market for the development, production, and marketing of drugs; Market for the marketing of dietary supplements. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e., November 2, 2026 NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration operation concerning the acquisition by the company \u201cLaprophan SA\u201d of the exclusive control of the company \u201cCorporate Investment Holding SA\u201d and its subsidiaries. \u201cLaprophan SA\u201d is a Moroccan joint-stock company, headquartered at Km 7, Route de l\u2019unit\u00e9, A\u00efn Seba\u00e2, Route de Rabat, Casablanca, registered with the Casablanca Trade Register under number 16499. It is active in the production, import, and distribution of pharmaceutical specialties and dietary supplements in Morocco, with recent expansion internationally through the acquisition of a majority stake in the companies \u201cPian Holding BV\u201d, \u201cRivopharm Limited\u201d, and \u201cDouble E Pharma Limited\u201d. \u201cCorporate Investment Holding SA\u201d is a Moroccan joint-stock company, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, Casablanca, registered with the Casablanca Trade Register under number 189919. It holds 98.4% of the share capital and voting rights of the company \u201cPolymedic SA\u201d, which itself holds 100% of the capital of the company \u201cSterilab SARL\u201d and associated voting rights. It also holds the entire share capital and voting rights of the companies \u201cPharmena SARLAU\u201d, \u201cPromaceutique SARLAU\u201d, and \u201cFonci\u00e8re Amyot SARLAU\u201d. \u201cPolymedic SA\u201d is a Moroccan joint-stock company, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, Casablanca, registered with the Casablanca Trade Register under number 29277. It is a pharmaceutical laboratory active in the manufacture and marketing of generic drugs and licensed specialties, as well as in contract manufacturing for third parties. It also recently started marketing dietary supplements. \u201cPharmena SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at Lot Dada, No. 77, Sal\u00e9, registered with the Sal\u00e9 Trade Register under number 18721. It is intended to be active in the distribution of dietary supplements and currently has no activity. \u201cPromaceutique SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 632273. It is active in consulting as well as information and promotion services for health or cosmetic products on behalf of the CIH group. \u201cFonci\u00e8re Amyot SARLAU\u201d is a single-member limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 632271. It is active in the acquisition, development, enhancement, and rehabilitation of real estate assets and holds the real estate assets of the entities affiliated with the company \u201cCorporate Investment Holding SA\u201d. \u201cSterilab SARL\u201d is a limited liability company under Moroccan law, headquartered at rue Amyot d\u2019Inville, Quartier Arsalane, A\u00efn Borja, Casablanca, registered with the Casablanca Trade Register under number 153299. It is intended to be active in the marketing of parapharmaceutical products, hygiene products, and medical equipment and currently has no activity. Done in Rabat, on October 22, 2026<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-49493","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n